TCL Archive FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI April 15, 1977
TCL Archive ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number June 17, 2011
TCL Archive AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation. April 14, 2006
TCL Archive Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says June 19, 1998
TCL Archive President Clinton Seeks 8% Increase For NCI; Most Institute Take Cuts In $10 Bll. NIH Budget April 16, 1993
